Is Ajooni Biotech Ltd debt-free?

Yes, Ajooni Biotech Ltd is debt-free with a debt-to-equity ratio of 0.02.

Home

Ajooni Biotech Ltd

Ajooni Biotech Ltd Financials

Ajooni Biotech Ltd Financial Statement

Ajooni Biotech Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Mar 2025	Dec 2024	Sep 2024
Revenue	30.61	34.42	26.03
Operating Expense	28.26	33.11	24.95
Net Profit	1.54	0.73	0.62
Net Profit Margin	5.03	2.12	2.38
Earning Per Share	0.09	0.04	0.04
EBIDTA	2.47	1.26	1.10
Effective Tax Rate	20.85	16.67	17.59

Particulars	Mar 2025
Revenue	30.61
Operating Expense	28.26
Net Profit	1.54
Net Profit Margin	5.03
Earning Per Share	0.09
EBIDTA	2.47
Effective Tax Rate	20.85

Ajooni Biotech Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	80.11	74.49	74.04
Operating Expenses Annual	77.88	71.72	70.96
Operating Profit Annual	4.43	3.06	3.11
Interest Annual	0.56	0.48	0.54
Depreciation	0.87	1.00	0.97
Net Profit Annual	2.16	1.12	1.05
Tax Annual	0.83	0.45	0.41

Particulars	Mar 2024
Total Revenue Annual	80.11
Operating Expenses Annual	77.88
Operating Profit Annual	4.43
Interest Annual	0.56
Depreciation	0.87
Net Profit Annual	2.16
Tax Annual	0.83

Ajooni Biotech Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	0.31	0.06	0.24
Cash Flow from Operations	-3.95	-5.58	3.68
Cash Flow from Investing	7.64	-15.82	-1.90
Cash Flow from Financing	-3.57	21.66	-1.97
Cash Flow at the End	0.43	0.31	0.06

Particulars	Mar 2024
Cash Flow at the Beginning	0.31
Cash Flow from Operations	-3.95
Cash Flow from Investing	7.64
Cash Flow from Financing	-3.57
Cash Flow at the End	0.43

Ajooni Biotech Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	5.53	4.11	4.20
PBIT Margin (%)	4.44	2.77	2.70
PBT Margin (%)	-3.47	-2.96	-2.30
Net PROFIT Margin (%)	2.70	1.50	1.42
Return On Networth / Equity (%)	5.12	3.86	6.55
Return On Networth /Employed (%)	7.72	5.97	9.05
Return On Assets (%)	4.69	3.26	4.75
Total Debt / Equity (X)	0.09	0.18	0.38
Asset Turnover Ratio (%)	1.74	2.17	3.35

Particulars	Mar 2024
PBDIT Margin (%)	5.53
PBIT Margin (%)	4.44
PBT Margin (%)	-3.47
Net PROFIT Margin (%)	2.70
Return On Networth / Equity (%)	5.12
Return On Networth /Employed (%)	7.72
Return On Assets (%)	4.69
Total Debt / Equity (X)	0.09
Asset Turnover Ratio (%)	1.74

Ajooni Biotech Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	10.32	6.29	6.21
Total Current Assets Annual	32.33	34.67	21.93
Non Current Assets Annual	15.19	24.06	7.09
Total Shareholders Funds Annual	42.71	41.67	16.38
Total Assets Annual	47.52	58.73	29.02

Particulars	Mar 2024
Fixed Assets Annual	10.32
Total Current Assets Annual	32.33
Non Current Assets Annual	15.19
Total Shareholders Funds Annual	42.71
Total Assets Annual	47.52

Ajooni Biotech Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

FAQS on Ajooni Biotech Ltd Financials

As of Jun 2, 2025, Ajooni Biotech Ltd has a market capitalization of 96.46 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Ajooni Biotech Ltd is with a debt-to-equity ratio of 0.02.

In FY 2024 , Ajooni Biotech Ltd recorded a total revenue of approximately 114.69 Cr marking a significant milestone in the company's financial performance.

Ajooni Biotech Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.5% and 0.2% annually, respectively..

Ajooni Biotech Ltd's current PE ratio is 28.62.

Ajooni Biotech Ltd's ROCE averaged 5.8% from the FY ending March 2023 to 2025, with a median of 5.2%. It peaked at 7.9% in March 2024, reflecting strong capital efficiency over the period..

Ajooni Biotech Ltd's latest EBIT is Rs. 4.66 Cr, surpassing the average EBIT of Rs. 3.43 Cr over the 5 years..